These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 2721655
21. [Ultrastructural alterations in colonic mucosa of nifurtimox treated rats]. Montalto de Mecca M, Rodríguez de Castro C, Díaz EG, Castro JA. Medicina (B Aires); 2001; 61(1):67-72. PubMed ID: 11265627 [Abstract] [Full Text] [Related]
22. Studies on pentane evolution by rats treated with nifurtimox or benznidazole. Castro GD, Castro JA. Toxicology; 1985 Jun 28; 35(4):319-26. PubMed ID: 4012799 [Abstract] [Full Text] [Related]
24. Benznidazole-induced ultrastructural and biochemical alterations in rat colon. Diaz EG, Rodriguez de Castro C, Montalto de Mecca M, Castro JA. Acta Pharmacol Sin; 2000 Nov 28; 21(11):961-6. PubMed ID: 11501063 [Abstract] [Full Text] [Related]
28. Experimental and Clinical Treatment of Chagas Disease: A Review. Sales Junior PA, Molina I, Fonseca Murta SM, Sánchez-Montalvá A, Salvador F, Corrêa-Oliveira R, Carneiro CM. Am J Trop Med Hyg; 2017 Nov 28; 97(5):1289-1303. PubMed ID: 29016289 [Abstract] [Full Text] [Related]
30. Genotoxicity studies with two antichagasic drugs. Nagel R. Mutat Res; 1987 May 28; 191(1):17-20. PubMed ID: 3553925 [No Abstract] [Full Text] [Related]
31. Sister-chromatid exchange in spleenic lymphocytes of mice after exposure to nifurtimox or benznidazole. Gorla NB. Mutat Res; 1987 Jun 28; 188(2):129-33. PubMed ID: 3587260 [Abstract] [Full Text] [Related]
32. Reductive metabolism and activation of benznidazole, a drug against Chagas' disease. Masana M, de Toranzo EG, Castro JA. Dev Toxicol Environ Sci; 1983 Jun 28; 11():383-6. PubMed ID: 6689570 [No Abstract] [Full Text] [Related]
33. Reactions of nifurtimox with critical sulfhydryl-containing biomolecules: their potential toxicological relevance. Díaz EG, Montalto de Mecca M, Castro JA. J Appl Toxicol; 2004 Jun 28; 24(3):189-95. PubMed ID: 15211612 [Abstract] [Full Text] [Related]
34. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection. Gulin JEN, Bisio M, Rocco DM, Altcheh J, Solana ME, García-Bournissen F. Exp Parasitol; 2018 Mar 28; 186():50-58. PubMed ID: 29448038 [Abstract] [Full Text] [Related]
35. Antibacterial activities of the antiparasitic drugs nifurtimox and benznidazole. Hof H. Antimicrob Agents Chemother; 1989 Mar 28; 33(3):404-5. PubMed ID: 2729935 [Abstract] [Full Text] [Related]
36. The reductive metabolism of nifurtimox and benznidazole in Crithidia fasciculata is similar to that in Trypanosoma cruzi. Moreno SN. Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988 Mar 28; 91(2):321-5. PubMed ID: 2905949 [Abstract] [Full Text] [Related]
37. Effect of nitroheterocyclic drugs on lipid peroxidation and glutathione content in rat liver extracts. Dubin M, Goijman SG, Stoppani AO. Biochem Pharmacol; 1984 Nov 01; 33(21):3419-23. PubMed ID: 6497901 [Abstract] [Full Text] [Related]
40. In vitro genotoxicity of nitroimidazoles as a tool in the search of new trypanocidal agents. Von Trompowsky ACM, Conde TR, Lemos RC, Quaresma BMC, Pitombeira MCS, de Carvalho AS, Boechat N, Salomão K, de Castro SL, Zamith HPDS. Mem Inst Oswaldo Cruz; 2019 Nov 01; 114():e190017. PubMed ID: 31271593 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]